Pramipexole Dihydrochloride Sustained Release Tablets Reference Listed Drug

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Name	Pramipexole Dihydrochloride Sustained Release Tablets
Trade name	Sifrol
Specifications	0.375mg ；0.75mg；1.5mg；3.0mg；4.5mg (calculated as C10H17N3S·2HCl·H2O)
Dosage form	Tablets (sustained release tablets)
Licensee	Boehringer Ingelheim International GmbH
Remarks	Original research import

Pratch resequence of the hydrochloride is a dopamine receptor agonist. The signs and symptoms used to treat special Parkinson's diseases, that is, during the entire disease, including the disease, when the effect of the left-handedorbar gradually decreases or changes and fluctuations (the dosage or ""switch"" fluctuations), You can apply this product (no left-free polyspin) or use it with left-handed multi-bar.

We are a global professional manufacturer and supplier of reference drug products, featuring high-quality services and competitive prices. You can get the most favorable reference drug prices here. If you need customized services, please contact us immediately.

Hot Tags: Pramipexole Dihydrochloride Sustained Release Tablets Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Agomelatine Tablets, Olanzapine Tablets, AdapaleneGel, Argatroban Injection, Reference Listed Drugs, Adefovir Dipivoxil Tablets

• Previous: Pramipexole Dihydrochloride Tablets Reference Listed Drug
• Next: Erlotinib Hydrochloride Tablets Reference Listed Drug